Autolus Therapeutics
AUTL | NASDAQ
$1.94
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.98
+$0.04 (+2.06%)
Pre-market:
Sep 22, 2026, 7:07 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 45.69M | 26.22M | 24.25M | 21.19M | 20.92M | 8.98M | 29K | n/a | n/a | 10.09M | n/a | 406K | n/a | 1.29M | 3.83M | 2.37M | n/a | n/a | 180K | 236K | 1.65M | 269K |
Cost of Revenue | 20.47M | 24.57M | 25.29M | 28.64M | 24.45M | 17.95M | 138.3M | 1.22M | n/a | 1.81M | 1.78M | 1.53M | n/a | 1.9M | 1.71M | 37.63M | n/a | 2.07M | 39.64M | 32.29M | 32.13M | 30.73M |
Gross Profit | 25.22M | 1.65M | -1.04M | -7.45M | -3.52M | -8.97M | -138.28M | -1.22M | n/a | 8.29M | -1.78M | -1.12M | n/a | -607K | 2.11M | -35.26M | n/a | -2.07M | -39.46M | -32.06M | -30.49M | -30.46M |
Operating Income | -43.84M | -59.51M | -72.36M | -71.62M | -61.22M | -65.24M | -241.43M | -68.87M | -58.93M | -38.76M | -40.89M | -44.05M | -44.35M | -35.38M | -30.3M | -81.13M | -46.48M | -41.95M | -86.78M | -72.65M | -69.85M | -69.93M |
Interest Income | 1.88M | 2.47M | 3.22M | 4.38M | 12.06M | 6.14M | 7.45M | 8.32M | 9.66M | 6.93M | 3.01M | 3.65M | 3.4M | 3.45M | 1.43M | 165K | 89K | 28K | 149K | 28K | 42K | 44K |
Pretax Income | -38.65M | -70.74M | -91.38M | -78.59M | -47.52M | -67.94M | -26.14M | -82.07M | -58.22M | -52.7M | -64.81M | -45.87M | -45.51M | -39.83M | -26.59M | -48.92M | -49.53M | -42.69M | -48.09M | -39.38M | -39.53M | -38.99M |
Net Income | -39.11M | -71.6M | -90.2M | -79.12M | -47.92M | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M | -45.85M | -45.55M | -39.81M | -26.95M | -42.77M | -42.06M | -37.06M | -41.67M | -33.99M | -33.17M | -33.27M |
Selling & General & Admin | 41.16M | 39.95M | 35.74M | 36.28M | 30.27M | 29.53M | 42.48M | 27.33M | 21.9M | 16.37M | 13.95M | 10.61M | 11.12M | 7.39M | 5.7M | 8.23M | 8.27M | 5.92M | 7.59M | 8.3M | 7.24M | 8.74M |
Research & Development | 27.9M | 21.21M | 35.58M | 27.89M | 27.43M | 26.73M | 50.53M | 40.32M | 36.61M | 30.67M | 25.16M | 32.32M | 33.23M | 27.39M | 26.71M | 37.63M | 38.21M | 33.96M | 39.74M | 32.29M | 32.13M | 30.73M |
Other Expenses | n/a | n/a | 1 | n/a | n/a | n/a | 10.14M | n/a | 414K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 69.06M | 61.16M | 71.32M | 64.17M | 57.7M | 56.27M | 103.15M | 67.65M | 58.93M | 47.04M | 39.11M | 42.93M | 44.35M | 34.77M | 32.41M | 45.86M | 46.48M | 39.88M | 47.33M | 40.59M | 39.37M | 39.47M |
Interest Expense | 2.67M | 11.11M | 22.8M | 10.52M | n/a | 10.14M | -30.84M | 10.69M | 10.17M | 19.27M | 30.13M | 5.01M | 5.02M | 4.91M | 3.46M | 1.85M | 1.81M | 1.79M | 1.11M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -24.93M | n/a | n/a | -1.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.34M | n/a | n/a | 324K |
Cost & Expenses | 89.53M | 85.73M | 96.62M | 92.82M | 82.14M | 74.22M | 241.46M | 68.87M | 58.93M | 48.85M | 40.89M | 44.45M | 44.35M | 36.67M | 34.12M | 83.5M | 46.48M | 41.95M | 86.96M | 72.88M | 71.5M | 70.2M |
Income Tax Expense | 465K | 861.55K | -1.18M | 532K | 397K | 2.23M | 1.46M | 22K | 51K | -8K | 12.36M | -21K | 40K | -14K | 359K | -6.15M | -7.47M | -5.62M | -6.43M | -5.39M | -6.36M | -5.72M |
Shares Outstanding (Basic) | 266.16M | 266.14M | 266.14M | 266.14M | 266.14M | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M | 173.83M | 117.18M | 90.99M | 90.93M | 90.91M | 72.9M | 72.9M | 70.83M | 62.45M |
Shares Outstanding (Diluted) | 266.16M | 266.14M | 266.14M | 266.14M | 266.14M | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M | 173.83M | 117.18M | 91.24M | 90.93M | 90.91M | 72.9M | 72.9M | 70.83M | 62.45M |
EPS (Basic) | -0.15 | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 | -0.57 | -0.47 | -0.47 | -0.53 |
EPS (Diluted) | -0.15 | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 | -0.57 | -0.47 | -0.47 | -0.53 |
EBITDA | -33.81M | -56.94M | -65.95M | -64.7M | -43.21M | -55.52M | -73.79M | -65.72M | -43.86M | -31.62M | -32.91M | -41.14M | -38.98M | -33.02M | -21.42M | -41.71M | -45.8M | -38.83M | -45.03M | -37.91M | -35.48M | -37.54M |
EBIT | -35.97M | -59.63M | -68.58M | -68.07M | -47.52M | -57.79M | -75.86M | -67.65M | -48.05M | -33.43M | -34.68M | -42.52M | -40.49M | -34.92M | -23.14M | -43.49M | -47.72M | -40.9M | -47.05M | -40.36M | -37.72M | -39.2M |
Depreciation & Amortization | 2.16M | 2.69M | 2.63M | 3.36M | 4.31M | 2.28M | 2.08M | 1.94M | 4.18M | 1.81M | 1.78M | 1.38M | 1.51M | 1.9M | 1.71M | 1.79M | 1.92M | 2.07M | 2.01M | 2.45M | 2.24M | 1.66M |
Add to Watchlist
Select watchlists to add or remove AUTL